Soluble epoxide hydrolase inhibitor attenuates BBB disruption and neuroinflammation after intracerebral hemorrhage in mice
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 150, 105197
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeysBritish Journal of Pharmacology, 2011
- Preclinical and clinical research on inflammation after intracerebral hemorrhageProgress in Neurobiology, 2010
- Structure and function of the blood–brain barrierNeurobiology of Disease, 2010
- Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vesselsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Antinociception Produced by 14,15-Epoxyeicosatrienoic Acid Is Mediated by the Activation of β-Endorphin and Met-Enkephalin in the Rat Ventrolateral Periaqueductal GrayThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Distribution and Expression of Soluble Epoxide Hydrolase in Human BrainJournal of Histochemistry & Cytochemistry, 2008
- Soluble Epoxide Hydrolase: A Novel Therapeutic Target in StrokeJournal of Cerebral Blood Flow & Metabolism, 2007
- Astrocytic Induction of Matrix Metalloproteinase-9 and Edema in Brain HemorrhageJournal of Cerebral Blood Flow & Metabolism, 2007
- Emerging Medical and Surgical Management Strategies in the Evaluation and Treatment of Intracerebral HemorrhageMayo Clinic Proceedings, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001